Try our Advanced Search for more refined results
Life Sciences
- 
									September 04, 2025
									RFK Renews Attacks On CDC At Fiery Capitol Hill AppearanceU.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. faced intense questioning from lawmakers on Capitol Hill on Thursday, with a handful of Republicans joining Democratic senators in voicing alarm over recent turmoil in vaccine policy and in leadership at the Centers for Disease Control and Prevention. 
- 
									September 04, 2025
									3rd Circ. Preview: Sept. Features Biosimilars, Gambling CasesThe Third Circuit's September argument lineup is packed with cases centering on the biosimilars segment of the pharmaceutical industry and gambling companies embroiled in disputes originating from New Jersey. 
- 
									September 04, 2025
									Sanofi Settles Conn. Zantac Suits Alleging Cancer RisksAfter more than a year of indicating settlement talks would likely be successful, Sanofi-Aventis US LLC and Sanofi US Services Inc. on Thursday announced accords in two Connecticut state court lawsuits that asserted that generic forms of brand name heartburn and acid reflux drug Zantac degraded into a substance that caused cancer. 
- 
									September 04, 2025
									Purdue Pharma Approved For $17.5M In Ch. 11 Bonus PlansBankrupt pharmaceutical company Purdue Pharma LP received approval from a New York judge Thursday to pay more than $17.5 million in employee bonuses, mirroring the bonus structures of the last few years since the company commenced its Chapter 11 case. 
- 
									September 04, 2025
									Ohio Cannabis Card Network Sued Over Faulty CybersecurityAn Ohio man is suing Ohio Medical Alliance LLC in federal court, alleging that its lackluster cybersecurity measures exposed more than 950,000 records containing private health information for its users. 
- 
									September 03, 2025
									7th Circ. Backs AbbVie's Win Against Ex-Sales Rep's FCA SuitThe Seventh Circuit declined to revive a former AbbVie employee's False Claims Act retaliation suit alleging he faced repercussions for refusing to push Vraylar's off-label use to treat major depressive disorder, ruling Wednesday he didn't put AbbVie on notice that he reasonably believed it was defrauding the government. 
- 
									September 03, 2025
									9th Circ. Won't Revive Genentech Ex-Worker's 401(k) SuitThe Ninth Circuit will not reconsider whether fiduciaries for the retirement plan of biotechnology company Genentech violated their duty to be prudent by keeping certain target date retirement funds in the company's retirement portfolio. 
- 
									September 03, 2025
									Fla. Surgeon General Pushes To End State's Vaccine MandatesFlorida's surgeon general on Wednesday said he intends to work toward undoing all of the state's vaccine mandates, including for schoolchildren. 
- 
									September 03, 2025
									Judge Backs Harvard In Suit Over Trump's $2B Fund FreezeThe Trump administration illegally froze more than $2 billion in grants earmarked for Harvard University when it failed to offer an explanation as to how cutting the funds addressed the government's stated goal of ending antisemitism on campus, a Massachusetts federal judge ruled Wednesday. 
- 
									September 03, 2025
									Novartis Inks Up To $5.2B Deal With Chinese Cardio BiotechChina's Argo Biopharmaceutical Co., a biotechnology company developing RNA-based medicines, said Wednesday it has struck an up to $5.2 billion deal with Novartis to advance several treatments for heart and blood vessel conditions. 
- 
									September 03, 2025
									NC Panel Revives Biotech Co.'s Legal Malpractice CaseA divided North Carolina appellate panel on Wednesday partially revived a biotech company's case accusing its former counsel of botching its defense in a $26 million defamation suit, finding the refiled complaint is not barred by the state's four-year statute of repose on legal malpractice claims. 
- 
									September 03, 2025
									Insurer Escapes Duty To Cover Lab's Suit Over COVID TestsContinental Casualty Co. is not obligated to cover a Pennsylvania laboratory in an underlying lawsuit brought by a COVID-19 test manufacturer that accuses the lab of neglecting its responsibilities and falsely disparaging its tests, a Pennsylvania federal judge ruled Friday, finding the claims are barred due to two exclusions within the insurer's policy. 
- 
									September 03, 2025
									Judge Accepts DNA Evidence In Gilgo Beach CaseA New York state court judge ruled Wednesday that DNA evidence allegedly linking accused Gilgo Beach serial killer Rex Heuermann to the bodies of women found dead on Long Island can be considered by a jury, marking the first time the scientific technique known as whole genome sequencing has passed such rigorous admissibility standards. 
- 
									September 02, 2025
									Auto Injection, Ypsomed Settle Insulin Pen Patent DisputeAuto Injection Technologies LLC said Tuesday that it has settled its lawsuit in Texas federal court claiming Swiss drugmaker Ypsomed infringed a pair of drug delivery patents acquired from Sanofi-Aventis. 
- 
									September 02, 2025
									Speculation Can't Halt Medical Coatings Merger, GTCR SaysGTCR BC Holdings LLC should be allowed to merge the nation's leading medical coatings supplier with the second leading provider because federal regulators spent two weeks simply relying on speculation and theory to prove its losing antitrust case, the private equity subsidiary argued. 
- 
									September 02, 2025
									$33M Pfizer Antitrust Deal OK'd, First MDL Trial Date SetA Pennsylvania federal judge has granted preliminary approval for a $33 million settlement between Pfizer and a class of direct purchasers claiming it fixed the prices of generic drugs, while also setting a date for the first bellwether trial in the antitrust litigation. 
- 
									September 02, 2025
									Confusion Over Slashed Patent Verdict Vexes Fed. Circ. JudgeAn attorney for Rex Medical butted heads with a Federal Circuit judge Tuesday over what a lower court actually did when it reduced a $10 million patent infringement verdict against Intuitive Surgical Inc. to $1, with the judge appearing frustrated by the confusion. 
- 
									September 02, 2025
									Ex-Executive Slaps Novo Nordisk Unit With Sex, Age Bias SuitA former finance director for a Novo Nordisk unit hit the company with a sex and age bias lawsuit last week, saying in a North Carolina federal court complaint that her career was cut short after she complained about workplace safety and discrimination. 
- 
									September 02, 2025
									Jury Clears Exela In Blood Pressure Drug Patent SuitA Delaware federal jury has cleared Exela Pharma Sciences in a suit claiming that its injection used to treat low blood pressure during anesthesia infringed patents owned by Nexus Pharmaceuticals. 
- 
									September 02, 2025
									CooperSurgical Says Earlier Cases Sink Conn. Filshie Clip SuitsCooperSurgical Inc. on Tuesday asked a Connecticut state judge to issue a win in its favor against several groups of women who say their birth control clips detached and migrated inside their bodies, accusing the women of forum shopping after their claims failed in several other states. 
- 
									September 02, 2025
									Defective Vascular Port Caused Man's Death, Suit SaysThe family of a Floridian who died after being implanted with an AngioDynamics Inc. vascular port hit the company with a suit in California federal court alleging that the device is defective and can cause multiple severe injuries including sepsis and death. 
- 
									September 02, 2025
									Gilead Rival Agrees Not To Sell Generic HIV Drug For NowA Gilead Sciences Inc. competitor has agreed not to sell a generic version of Gilead's human immunodeficiency virus treatment Biktarvy until a trio of patents expire, according to a proposal by the parties to end infringement allegations. 
- 
									September 02, 2025
									Post-Ch. 11 Teligent 'Caremark' Suit Moves Forward In Del.In a rare decision, Delaware's chancellor on Tuesday kept alive "Caremark" duty of oversight claims against most former officers and directors of a generic-drug maker previously known as Teligent. 
- 
									September 02, 2025
									Wells Fargo Employee Drug Cost Battle: What To KnowA group of former Wells Fargo employees is back in federal court this week with allegations the company mismanaged their prescription drug benefits, leading to millions in overpayments. The banking giant says the case is a do-over of allegations already axed by the Minnesota court 
- 
									September 02, 2025
									'Never My Intention' To Defy Justices, Judge In NIH Case SaysA veteran Massachusetts jurist on Tuesday responded to suggestions by two U.S. Supreme Court justices that he had defied the high court by going ahead with a bench trial on two challenges to the Trump administration's cuts to National Institutes of Health research grants, saying he would never intentionally disregard precedent. 
Expert Analysis
- 
								Series Brazilian Jiujitsu Makes Me A Better Lawyer  Competing in Brazilian jiujitsu – often against opponents who are much larger and younger than me – has allowed me to develop a handful of useful skills that foster the resilience and adaptability necessary for a successful legal career, says Tina Dorr of Barnes & Thornburg. 
- 
								
								Fed. Circ. In April: Introducing New Evidence During IPR  The Federal Circuit's decision in Sage Products v. Stewart last month upheld the Patent Trial and Appeal Board's decision to allow a petitioner to rely on case-dispositive evidence beyond prior art references, affording petitioners in inter partes review proceedings greater latitude in the timing of evidence presentation, say attorneys at Knobbe Martens. 
- 
								
								FDA Commissioner Speech Suggests New Vision For Agency.jpg)  In his first public remarks as U.S. Food and Drug Administration commissioner, Marty Makary outlined an ambitious framework for change centered around cultural restoration, scientific integrity, regulatory flexibility and selective modernization, and substantial enforcement shifts for the food and tobacco sectors, say attorneys at Arnall Golden. 
- 
								
								DOJ Export Declination Highlights Self-Reporting Benefits  The U.S. Department of Justice's recent decision not to prosecute a NASA contractor, despite a former employee pleading guilty to facilitating unlicensed exports, underscores the advantages available to companies that self-report sanctions violations, cooperate with investigations and implement timely remediation, say attorneys at Cleary. 
- 
								
								AG Watch: Texas Expands Use Of Consumer Protection Laws.jpg)  In recent years under Attorney General Ken Paxton, Texas has demonstrated the breadth of its public interest authority by bringing actions in areas not traditionally associated with consumer protection law, including recent actions involving sports and public safety, say attorneys at Kelley Drye. 
- 
								Series Power To The Paralegals: An Untapped Source For Biz Roles  Law firms looking to recruit legal business talent should consider turning to paralegals, who practice several key skills every day that prepare them to thrive in marketing and client development roles, says Vanessa Torres at Lowenstein Sandler. 
- 
								
								A Path Forward For Colo. Pot Products After Failed Safety Test.jpg)  As cannabis products in Colorado face increasingly rigorous contamination testing, decontamination and remediation can be an alternative to destruction after a failed safety check, in certain circumstances, so understanding the nuances of these procedures is vital, say attorneys at Troutman Pepper. 
- 
								Series Playing Poker Makes Me A Better Lawyer  Poker is a master class in psychology, risk management and strategic thinking, and I’m a better attorney because it has taught me to read my opponents, adapt when I’m dealt the unexpected and stay patient until I'm ready to reveal my hand, says Casey Kingsley at McCreadyLaw. 
- 
								
								What EU 'Killer Acquisition' Study Means For Pharma Deals  The European Commission’s recent study of pharmaceutical companies' acquisitions of emerging competitive threats, the first of its kind globally, has important implications for the industry, and may lead to increased awareness of merger control risks in collaborative agreements, say lawyers at Paul Weiss. 
- 
								
								Legal Risks For Providers Discussing Psychedelic Therapies  The emergence of psychedelic therapies as potential treatments for mental health conditions and other ailments continues to garner significant attention, but the legal landscape surrounding discussions and referrals remains fraught with complexity, creating potential risks for healthcare providers and institutions, says Kimberly Chew at Husch Blackwell. 
- 
								Series Law School's Missed Lessons: Becoming A Firmwide MVP  Though lawyers don't have a neat metric like baseball players for measuring the value they contribute to their organizations, the sooner new attorneys learn skills frequently skipped in law school — like networking, marketing, client development and case evaluation — the more valuable, and less replaceable, they will be, says Alex Barnett at DiCello Levitt. 
- 
								
								Trade Secrets Would Likely See Court Protection From GenAI  The advent of generative artificial intelligence has given rise to debate about how this technology will affect intellectual property rights and trade secret protections in particular, but courts to date have protected owners when technological advances have facilitated new means for trade secret theft, say attorneys at Kilpatrick Townsend. 
- 
								
								A Breakdown Of Trump's Order On Drug Pricing  The Trump administration may attempt to effectuate through rulemaking a recently issued executive order on lowering drug prices, which would likely have an adverse effect on stakeholders and trigger litigation, say attorneys at Debevoise. 
- 
								
								Cosmetic Co. Considerations As More States Target PFAS  In the first quarter of the year, seven states introduced or passed legislation focused on banning the sale of cosmetics that contain PFAS, making it necessary for businesses to adjust their product testing and supply chain practices, product formulations, marketing strategies, and more, say attorneys at Alston & Bird. 
- 
								
								Del. Bill Reflects Nat'l Tug-Of-War Between Cannabis, Alcohol  As Delaware's bill targeting hemp-derived THC beverages and ingestible products moves through the general assembly, it reads like a local regulatory fix — but in reality, it's a microcosm of a national power struggle playing out state-by-state across the cannabis frontier, says attorney Peter Murphy.